BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27855950)

  • 21. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy].
    Duléry R; Giraud C; Beaumont JL; Bilger K; Borel C; Dhedin N; Thiebaut A; Willems E; Alain S; Alfandari S; Dewilde A; Jouet JP; Milpied N; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):158-9. PubMed ID: 24011965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improving diagnosis coding in the ProMise database: Guidelines of the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Polge E; Bourgue F; Cuvelier M; Pires B; Hugon N; Laurent N; Leclerc N; Leroux S; Le Bars L; Marion S; Meziane Y; Moukhtari L; Renault M; Peffault de Latour R; Yakoub-Agha I; Raus N
    Bull Cancer; 2016 Nov; 103(11S):S213-S219. PubMed ID: 27842859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation.
    Schellekens J; Rozemuller EH; Petersen EJ; van den Tweel JG; Verdonck LF; Tilanus MG
    Mol Immunol; 2008 Feb; 45(4):981-9. PubMed ID: 17881057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Information and consent forms for hematopoietic stem cell transplantation donors and recipients: Guidelines from the Franchophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Bruno B; Thibert JB; Bancillon N; Desbos A; Fawaz A; Fournier I; Genty C; Issarni D; Leveille S; Premel C; Polomeni A; Renault M; Tarillon S; Wallart A; Yakoub-Agha I; Bordessoule D
    Bull Cancer; 2016 Nov; 103(11S):S198-S200. PubMed ID: 27842861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preservation/congelation of hematopoietic stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    De Vos J; de Berranger E; Jubert C; Pochon C; Letellier C; Mialou V; Sirvent A; Yakoub-Agha I; Dalle JH
    Bull Cancer; 2017 Dec; 104(12S):S136-S141. PubMed ID: 29169651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY; Ren HY; Cen XN; Qiu ZX; Wang LH; Ou JP; Li Y; Wang MJ; Wang WS; Xu WL; Dong YJ; Yin Y; Sun YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):155-60. PubMed ID: 23484711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of the chronic graft versus host disease: Guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)].
    Magro L; Forcade E; Giraud C; Granata A; Parquet N; Rohrlich PS; Terriou L; Yakoub-Agha I; Beguin Y
    Bull Cancer; 2017 Dec; 104(12S):S145-S168. PubMed ID: 29174321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of NK cell activity in cure by transplant.
    Leung W
    Br J Haematol; 2011 Oct; 155(1):14-29. PubMed ID: 21812770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)].
    Maria ATJ; Campidelli A; Castilla-Llorente C; Lansiaux P; Marjanovic Z; Pugnet G; Torregrosa-Diaz JM; Terriou L; Algayres JP; Urbain F; Yakoub-Agha I; Farge D
    Bull Cancer; 2023 Feb; 110(2S):S97-S107. PubMed ID: 36658011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test].
    Duléry R; Giraud C; Beaumont JL; Bilger K; Borel C; Dhedin N; Thiebaut A; Willems E; Alain S; Alfandari S; Dewilde A; Jouet JP; Milpied N; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):155-7. PubMed ID: 24011960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Pugnet G; Castilla-Llorente C; Puyade M; Terriou L; Badoglio M; Deligny C; Guillaume-Jugnot P; Labeyrie C; Benzidia I; Faivre H; Lansiaux P; Marjanovic Z; Bourhis JH; Faucher C; Furst S; Huynh A; Martin T; Vermersch P; Yakoub-Agha I; Farge D
    Bull Cancer; 2017 Dec; 104(12S):S169-S180. PubMed ID: 29173974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
    Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
    Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Conrad A; Beguin Y; Guenounou S; Le Bourgeois A; Ménard AL; Rialland F; Layal S; Mamez AC; Yakoub-Agha I; El Cheikh J
    Bull Cancer; 2024 Feb; 111(2S):S40-S49. PubMed ID: 37479644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Loschi M; Alsuliman T; Cabrera Q; Desbrosses Y; Desmier D; Yakoub Agha I; Guillaume T
    Bull Cancer; 2024 Feb; 111(2S):S22-S28. PubMed ID: 36922321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC].
    Bonnin A; Terriou L; Beuvon C; Tudesq JJ; Puyade M; Pugnet G; Maria A; Llorente CC; Lansiaux P; Cacciatore C; Badoglio M; Yakoub-Agha I; Farge-Bancel D; Marjanovic Z
    Bull Cancer; 2024 Feb; 111(2S):S84-S95. PubMed ID: 37845095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relapse with HLA loss after hematopoietic stem cell transplantation with non-HLA identical donor: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Amokrane K; Cherel M; Rouzaire PO; Walencik A; Dubois V
    Bull Cancer; 2024 Feb; 111(2S):S14-S21. PubMed ID: 37061368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.